The European Lung Cancer Congress (ELCC 2022), from 30 March-2 April 2022, was held virtually this year and showcased recent developments in the prevention, screening, and early detection of thoracic malignancies, as well as the current and emerging contribution of precision medicine, big data and artificial intelligence, biomarkers and liquid biopsies in the optimal management of patients with lung cancer.
#ASCO22 Excited for these #LCSM studies which may be practice-relevant đŠââď¸đ¨ââď¸, organized đ by setting/tumor type. Looking forward to seeing some #LCSMChampions IRL @ASCO and a lot of learning! Please add other #LCSM studies you are looking forward to đ @OncoAlert @LUNGevity
Catherine Alix-Panabieres of University Medical Center of Montpellier talks on the clinical relevance of liquid biopsy and circulating tumor cells for precision medicine
The European Lung Cancer Congress (ELCC 2022), from 30 March-2 April 2022, was held virtually this year and showcased recent developments in the prevention, screening, and early detection of thoracic malignancies, as well as the current and emerging contribution of precision medicine, big data and artificial intelligence, biomarkers and liquid biopsies in the optimal management of patients with lung cancer.
#ASCO22 Excited for these #LCSM studies which may be practice-relevant đŠââď¸đ¨ââď¸, organized đ by setting/tumor type. Looking forward to seeing some #LCSMChampions IRL @ASCO and a lot of learning! Please add other #LCSM studies you are looking forward to đ @OncoAlert @LUNGevity
Catherine Alix-Panabieres of University Medical Center of Montpellier talks on the clinical relevance of liquid biopsy and circulating tumor cells for precision medicine
Lung Cancer Sessions: BTOG 2022 highlights & UK lung cancer care
Watch leading UK lung cancer experts Sanjay Popat, Alastair Greystoke, Anna Minchom & Robert Rintouldiscuss the important learnings from the British Thoracic Oncology Group (BTOG) Annual Meeting 2022.